Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casey C Kopczynski
David L Epstein

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 6, 2013
Emerging trabecular outflow drugsCasey C Kopczynski, David L Epstein
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 11, 2015
Effect of AR-13324 on episcleral venous pressure in Dutch belted rabbitsJeffrey W Kiel, Casey C Kopczynski
Ophthalmology and Therapy|November 27, 2020
A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle GlaucomaJames H Peace, Hayley J McKee, Casey C Kopczynski
Ophthalmology|October 2, 2014
Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressureJason Bacharach, Harvey B Dubiner, Brian Levy, et al.
Investigative Ophthalmology & Visual Science|May 8, 2012
From discovery to the clinic: lessons learnedDavid L Epstein
Investigative Ophthalmology & Visual Science|August 7, 2013
Soaring aspirations: lessons from my mentors and colleagues: the Weisenfeld awardDavid L Epstein
Investigative Ophthalmology & Visual Science|May 8, 2012
Framing glaucoma questions: what are the opportunities for glaucoma treatment? A personal perspectiveDavid L Epstein
The British Journal of Ophthalmology|July 26, 2015
Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertensionRichard A Lewis, Brian Levy, Nancy Ramirez, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 23, 2018
The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in HumansArash Kazemi, Jay W McLaren, Casey C Kopczynski, et al.
Frontiers in Ophthalmology|July 10, 2024
Effects of Netarsudil-Family Rho Kinase Inhibitors on Human Trabecular Meshwork Cell Contractility and Actin Remodeling Using a Bioengineered ECM HydrogelTyler Bagué, Ayushi Singh, Rajanya Ghosh, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 6, 2013
Emerging trabecular outflow drugsCasey C Kopczynski, David L Epstein
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 11, 2015
Effect of AR-13324 on episcleral venous pressure in Dutch belted rabbitsJeffrey W Kiel, Casey C Kopczynski
Ophthalmology and Therapy|November 27, 2020
A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle GlaucomaJames H Peace, Hayley J McKee, Casey C Kopczynski
Ophthalmology|October 2, 2014
Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressureJason Bacharach, Harvey B Dubiner, Brian Levy, et al.
Investigative Ophthalmology & Visual Science|May 8, 2012
From discovery to the clinic: lessons learnedDavid L Epstein
Investigative Ophthalmology & Visual Science|August 7, 2013
Soaring aspirations: lessons from my mentors and colleagues: the Weisenfeld awardDavid L Epstein
Investigative Ophthalmology & Visual Science|May 8, 2012
Framing glaucoma questions: what are the opportunities for glaucoma treatment? A personal perspectiveDavid L Epstein
The British Journal of Ophthalmology|July 26, 2015
Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertensionRichard A Lewis, Brian Levy, Nancy Ramirez, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 23, 2018
The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in HumansArash Kazemi, Jay W McLaren, Casey C Kopczynski, et al.
Frontiers in Ophthalmology|July 10, 2024
Effects of Netarsudil-Family Rho Kinase Inhibitors on Human Trabecular Meshwork Cell Contractility and Actin Remodeling Using a Bioengineered ECM HydrogelTyler Bagué, Ayushi Singh, Rajanya Ghosh, et al.
Pageof 9